Clinical Proteomics

Papers
(The TQCC of Clinical Proteomics is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Recent advances in mass spectrometry based clinical proteomics: applications to cancer research166
Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer’s disease52
A comprehensive systematic review of CSF proteins and peptides that define Alzheimer’s disease40
Mass spectrometry-based microbiological testing for blood stream infection39
Laser capture microdissection coupled mass spectrometry (LCM-MS) for spatially resolved analysis of formalin-fixed and stained human lung tissues37
Using phosphoproteomics data to understand cellular signaling: a comprehensive guide to bioinformatics resources35
CSF extracellular vesicle proteomics demonstrates altered protein homeostasis in amyotrophic lateral sclerosis26
Proteomic analysis of synovial fluid from rheumatic arthritis and spondyloarthritis patients25
Circulating proteins as predictive and prognostic biomarkers in breast cancer23
Effects of cryopreservation and long-term culture on biological characteristics and proteomic profiles of human umbilical cord-derived mesenchymal stem cells20
Clinical proteomics for prostate cancer: understanding prostate cancer pathology and protein biomarkers for improved disease management19
The plasma peptides of Alzheimer’s disease19
Proteomic analysis of human synovial fluid reveals potential diagnostic biomarkers for ankylosing spondylitis19
Proteomic analysis of decidua in patients with recurrent pregnancy loss (RPL) reveals mitochondrial oxidative stress dysfunction18
Tear proteomic profile in three distinct ocular surface diseases: keratoconus, pterygium, and dry eye related to graft-versus-host disease17
The plasma peptides of sepsis16
Identification of pathogens from native urine samples by MALDI-TOF/TOF tandem mass spectrometry16
A proteomic repertoire of autoantigens identified from the classic autoantibody clinical test substrate HEp-2 cells15
Label-free proteomic analysis of serum exosomes from paroxysmal atrial fibrillation patients15
Urine proteomics identifies biomarkers for diabetic kidney disease at different stages15
Quantitative proteomics-based analyses performed on pre-eclampsia samples in the 2004–2020 period: a systematic review14
Circulating microvesicles and exosomes in small cell lung cancer by quantitative proteomics14
Rational selection of a biomarker panel targeting unmet clinical needs in kidney injury14
Mass spectrometry-based proteomics in basic and translational research of SARS-CoV-2 coronavirus and its emerging mutants13
Secreted protein markers in oral squamous cell carcinoma (OSCC)12
Variable blood processing procedures contribute to plasma proteomic variability12
Human follicular fluid proteome reveals association between overweight status and oocyte maturation abnormality10
Identification of TUBB2A by quantitative proteomic analysis as a novel biomarker for the prediction of distant metastatic breast cancer10
A nomogram based on glycomic biomarkers in serum and clinicopathological characteristics for evaluating the risk of peritoneal metastasis in gastric cancer10
Proteomic and phosphoproteomic measurements enhance ability to predict ex vivo drug response in AML10
Optimized sample preparation and data analysis for TMT proteomic analysis of cerebrospinal fluid applied to the identification of Alzheimer’s disease biomarkers10
Evaluation of the potential of Pap test fluid and cervical swabs to serve as clinical diagnostic biospecimens for the detection of ovarian cancer by mass spectrometry-based proteomics10
Development of a novel method for the quantification of tyrosine 39 phosphorylated α- and β-synuclein in human cerebrospinal fluid10
A SISCAPA-based approach for detection of SARS-CoV-2 viral antigens from clinical samples10
Quantitative analysis of differentially expressed proteins in psoriasis vulgaris using tandem mass tags and parallel reaction monitoring9
Combined proteomic/transcriptomic signature of recurrence post-liver transplantation for hepatocellular carcinoma beyond Milan9
Quantitative proteomic analysis of serum-purified exosomes identifies putative pre-eclampsia-associated biomarkers9
Proteomic analysis identifies a signature of disease severity in the plasma of COVID-19 pneumonia patients associated to neutrophil, platelet and complement activation9
Mass spectrometry-based proteomics as an emerging tool in clinical laboratories9
Optimized data-independent acquisition approach for proteomic analysis at single-cell level9
Proteomic approaches for characterizing renal cell carcinoma8
Quantitative proteomics analysis of lysine 2-hydroxyisobutyrylation in IgA nephropathy8
Identification of circular RNA BTBD7_hsa_circ_0000563 as a novel biomarker for coronary artery disease and the functional discovery of BTBD7_hsa_circ_0000563 based on peripheral blood mononuclear cell8
Data-independent acquisition mass spectrometry in severe rheumatic heart disease (RHD) identifies a proteomic signature showing ongoing inflammation and effectively classifying RHD cases7
A rigorous evaluation of optimal peptide targets for MS-based clinical diagnostics of Coronavirus Disease 2019 (COVID-19)7
A robust multiplex immunoaffinity mass spectrometry assay (PromarkerD) for clinical prediction of diabetic kidney disease7
Proteome profiling of human placenta reveals developmental stage-dependent alterations in protein signature7
Analytical validation of a multi-biomarker algorithmic test for prediction of progressive kidney function decline in patients with early-stage kidney disease7
Subclinical effects of remote ischaemic conditioning in human kidney transplants revealed by quantitative proteomics7
LC-MS/MS based metabolomics and proteomics reveal candidate biomarkers and molecular mechanism of early IgA nephropathy7
0.017411947250366